XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes to the consolidated financial statements - Research and development expenses (Details) - Research and development expenses - EUR (€)
€ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Notes to the consolidated financial statements    
Materials € (29,618) € (5,893)
Personnel (24,326) (25,209)
Amortization and depreciation (3,866) (3,051)
Patents and fees to register a legal right (2,536) (2,372)
Third-party services 28,525 (246,185)
Maintenance and lease (789) (291)
Other (2,324) (1,727)
Total (34,934) (284,728)
Salary and salary-related expenses 23,846 24,637
Expenses from share-based payments 480 € 572
Reversal of provision of onerous contracts € 36,769